Menkes Disease clinical trials at University of California Health

1 in progress, 0 open to eligible people

Copper Histidinate Treatment for Menkes Disease
Sorry, not accepting new patients
This expanded access protocol provides subcutaneous copper histidinate for Menkes disease patients under 6 years of age.
at UC Davis

Last updated: June 26, 2025